Cargando…

Analysis of acute lymphoblastic leukemia drug sensitivity by changes in impedance via stromal cell adherence

The bone marrow is a frequent location of primary relapse after conventional cytotoxic drug treatment of human B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Because stromal cells have a major role in promoting chemotherapy resistance, they should be included to more realistically model in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luong, Annie, Cerignoli, Fabio, Abassi, Yama, Heisterkamp, Nora, Abdel-Azim, Hisham
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483355/ https://www.ncbi.nlm.nih.gov/pubmed/34591931 http://dx.doi.org/10.1371/journal.pone.0258140

Ejemplares similares

B-cell precursor acute lymphoblastic leukemia and stromal cells communicate through Galectin-3
por: Fei, Fei, et al.
Publicado: (2015)

Overcoming Microenvironment-Mediated Chemoprotection through Stromal Galectin-3 Inhibition in Acute Lymphoblastic Leukemia
por: Tarighat, Somayeh S., et al.
Publicado: (2021)

Phosphoflow-Based Evaluation of Mek Inhibitors as Small-Molecule Therapeutics for B-Cell Precursor Acute Lymphoblastic Leukemia
por: George, Aswathi A., et al.
Publicado: (2015)

Treatment of B-cell precursor acute lymphoblastic leukemia with the Galectin-1 inhibitor PTX008
por: Paz, Helicia, et al.
Publicado: (2018)

Cytotoxicity of CD56-positive lymphocytes against autologous B-cell precursor acute lymphoblastic leukemia cells
por: Fei, Fei, et al.
Publicado: (2014)

Pre-B acute lymphoblastic leukemia expresses cell surface nucleolin as a 9-O-acetylated sialoglycoprotein
por: Joo, Eun Ji, et al.
Publicado: (2018)

O-acetylated N-acetylneuraminic acid as a novel target for therapy in human pre-B acute lymphoblastic leukemia
por: Parameswaran, Reshmi, et al.
Publicado: (2013)

Using impedance-based approaches for measuring cell-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity (ADCC)
por: Lamarche, Brandon, et al.
Publicado: (2015)

Combination of drug therapy in acute lymphoblastic leukemia with a CXCR4 antagonist
por: Parameswaran, Reshmi, et al.
Publicado: (2011)

Glycoproteome remodeling in MLL-rearranged B-cell precursor acute lymphoblastic leukemia
por: Oliveira, Tiago, et al.
Publicado: (2021)

Environment-mediated drug resistance in Bcr/Abl-positive acute lymphoblastic leukemia
por: Feldhahn, Niklas, et al.
Publicado: (2012)

In vitro immunotherapy potency assays using real-time cell analysis
por: Cerignoli, Fabio, et al.
Publicado: (2018)

Characterizing Deformability of Drug Resistant Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells Using Acoustic Tweezers
por: Liu, Hsiao-Chuan, et al.
Publicado: (2018)

AMD3100 sensitizes acute lymphoblastic leukemia cells to chemotherapy in vivo
por: Yu, M, et al.
Publicado: (2011)

Development of resistance to dasatinib in Bcr/Abl-positive acute lymphoblastic leukemia
por: Fei, Fei, et al.
Publicado: (2010)

Galectin-1 and Galectin-3 in B-Cell Precursor Acute Lymphoblastic Leukemia
por: Fei, Fei, et al.
Publicado: (2022)

Treatment of acute lymphoblastic leukemia with an rGel/BLyS fusion toxin
por: Parameswaran, Reshmi, et al.
Publicado: (2012)

Eosinophilic presentation of acute lymphoblastic leukemia
por: Rezamand, Azim, et al.
Publicado: (2013)

Compliance and adherence of patients in the treatment of acute lymphoblastic leukemia
por: Barr, Ronald Duncan
Publicado: (2011)

Nilotinib treatment in mouse models of P190 Bcr/Abl lymphoblastic leukemia
por: Kaur, Pavinder, et al.
Publicado: (2007)

Bayesian modelling of response to therapy and drug-sensitivity in acute lymphoblastic leukemia
por: Cremaschi, Andrea, et al.
Publicado: (2023)

Stromal-induced epithelial-mesenchymal transition induces targetable drug resistance in acute lymphoblastic leukemia
por: Park, Chun Shik, et al.
Publicado: (2023)

Multi-Faceted Effects of ST6Gal1 Expression on Precursor B-Lineage Acute Lymphoblastic Leukemia
por: Zhang, Mingfeng, et al.
Publicado: (2022)

Long-term response to autologous anti-CD19 chimeric antigen receptor T cells in relapsed or refractory B cell acute lymphoblastic leukemia: a systematic review and meta-analysis
por: Elsallab, Magdi, et al.
Publicado: (2023)

Treatment of human pre-B acute lymphoblastic leukemia with the Aurora kinase inhibitor PHA-739358 (Danusertib)
por: Fei, Fei, et al.
Publicado: (2012)

Minimal Residual Disease Detection in Acute Lymphoblastic Leukemia
por: Kruse, Aaron, et al.
Publicado: (2020)

Adherence to 6-Mercaptopurine in children and adolescents with Acute Lymphoblastic Leukemia
por: Alsous, Mervat, et al.
Publicado: (2017)

Targeting miR-126 in Ph+ acute lymphoblastic leukemia
por: Qiao, Junjing, et al.
Publicado: (2023)

Investigating causes and risk factors of pre-chemotherapy viremia in acute lymphoblastic leukemia pediatric patients
por: Abdel-azim, Nivin, et al.
Publicado: (2022)

Stromal cell-mediated mitochondrial redox adaptation regulates drug resistance in childhood acute lymphoblastic leukemia
por: Liu, Jizhong, et al.
Publicado: (2015)

Clinical Impact of Drug Adherence of Tyrosine Kinase Inhibitors in Children with Ph-Positive Acute Lymphoblastic Leukemia
por: Wang, Jun-Xia, et al.
Publicado: (2023)

Sensitization to Drug Treatment in Precursor B-Cell Acute Lymphoblastic Leukemia Is Not Achieved by Stromal NF-κB Inhibition of Cell Adhesion but by Stromal PKC-Dependent Inhibition of ABC Transporters Activity
por: Ruiz-Aparicio, Paola Fernanda, et al.
Publicado: (2021)

Support of acute lymphoblastic leukemia cells by nonmalignant bone marrow stromal cells
por: Usmani, Sana, et al.
Publicado: (2019)

Sensitivity to Pain in Children With Acute Lymphoblastic Leukemia (ALL)
por: Firoozi, Manijeh, et al.
Publicado: (2012)

Ex vivo Drug Sensitivity Imaging-based Platform for Primary Acute Lymphoblastic Leukemia Cells
por: Rowland, Lauren, et al.
Publicado: (2023)

Biological Features of Bone Marrow Mesenchymal Stromal Cells in Childhood Acute Lymphoblastic Leukemia
por: Genitsari, Stella, et al.
Publicado: (2018)

Preclinical Evaluation of a Novel Dual Targeting PI3Kδ/BRD4 Inhibitor, SF2535, in B-Cell Acute Lymphoblastic Leukemia
por: Ruan, Yongsheng, et al.
Publicado: (2021)

CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression
por: Fousek, Kristen, et al.
Publicado: (2020)

Senescent stromal cell-induced divergence and therapeutic resistance in T cell acute lymphoblastic leukemia/lymphoma
por: Habiel, David M., et al.
Publicado: (2016)

Expression of miR-652-3p and Effect on Apoptosis and Drug Sensitivity in Pediatric Acute Lymphoblastic Leukemia
por: Jiang, Qian, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_anqa024fohut89bjnksom1gkdm